Last updated on August 2009

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose


Brief description of study

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Detailed Study Description

Blood Pressure and Metabolic Effects of Nebivolol Compared with Hydrochlorothiazide and Placebo in Hypertensive patients with Impaired Glucose Tolerance or Impaired Fasting Glucose.

Inclusion Criteria:

  • Male or female, ambulatory outpatients 18-80 years old at screening.
  • Have a history of hypertension
  • Qualifying laboratory results

Exclusion Criteria:

  • Severe Hypertension, including chronic renal disease
  • Use of niacin or anti-diabetic medication (oral or injectable) within 6 months of study
  • Have clinically significant respiratory, liver, or cardiovascular disease
  • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates
  • Have a history of hypersensitivity to nebivolol, other beta-blockers, or other sulfonomide-derived drugs.

Clinical Study Identifier: TX134527

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Diablo Clinical Research

Diablo Clinical Research
Walnut Creek, CA USA
  Connect »